Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Philip Sung-En Wang, Dr.P.H., M.D.

Concepts (353)

Back to Profile

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name	Number of Publications	Most Recent Publication	Publications by All Authors	Concept Score	Why?
Mental Health Services	18	2010	1730	1.390	Why?
Antidepressive Agents	12	2010	2897	1.280	Why?
Mental Disorders	26	2010	6841	1.160	Why?
Depressive Disorder	10	2010	3728	1.070	Why?
Antipsychotic Agents	13	2009	3068	1.040	Why?
Community Mental Health Services	3	2010	392	0.780	Why?
National Institute of Mental Health (U.S.)	3	2010	107	0.750	Why?
Suicide, Attempted	5	2010	1398	0.720	Why?
Health Services Research	9	2010	1812	0.640	Why?
Health Surveys	17	2009	4059	0.630	Why?
Absenteeism	6	2008	247	0.630	Why?
Depression	9	2022	8122	0.550	Why?
Suicide	4	2010	1598	0.550	Why?
Cost Sharing	2	2010	409	0.500	Why?
Mood Disorders	7	2010	1127	0.480	Why?
Health Services Needs and Demand	7	2010	1403	0.480	Why?
Work	2	2006	195	0.470	Why?
Psychotropic Drugs	4	2009	888	0.460	Why?
Clozapine	4	2007	506	0.440	Why?
Health Policy	5	2010	2684	0.440	Why?
Pharmacogenetics	2	2009	675	0.430	Why?
Comorbidity	20	2022	10498	0.390	Why?
Cost-Benefit Analysis	8	2010	5492	0.390	Why?
Disasters	2	2007	519	0.380	Why?
Patient Compliance	5	2005	2690	0.380	Why?
Adolescent Health Services	2	2010	218	0.350	Why?
British Columbia	6	2010	241	0.340	Why?
Antihypertensive Agents	3	2005	2023	0.340	Why?
Drug Prescriptions	7	2006	1669	0.330	Why?
Substance-Related Disorders	7	2010	4420	0.320	Why?
Cost of Illness	4	2009	1936	0.300	Why?
Efficiency	3	2007	476	0.300	Why?
Depressive Disorder, Major	8	2009	4760	0.290	Why?
Employer Health Costs	1	2006	21	0.280	Why?
World Health Organization	3	2009	1316	0.280	Why?
Hip Fractures	2	2005	988	0.270	Why?
Drug Therapy	2	2008	503	0.270	Why?
School Health Services	1	2010	384	0.260	Why?
Psychotic Disorders	7	2009	3223	0.260	Why?
Community-Institutional Relations	1	2007	206	0.260	Why?
United States	38	2010	72339	0.260	Why?
Medication Systems	1	2005	32	0.250	Why?
Prevalence	16	2022	15717	0.250	Why?
Task Performance and Analysis	2	2006	761	0.250	Why?
Arrhythmias, Cardiac	2	2007	2246	0.250	Why?
Health Care Surveys	4	2007	2426	0.240	Why?
Behavioral Symptoms	1	2006	186	0.240	Why?
Drug Costs	2	2010	1183	0.240	Why?
Schizophrenia	4	2009	6937	0.240	Why?
Workplace	2	2008	863	0.240	Why?
Lung Diseases, Obstructive	1	2005	308	0.230	Why?
Child Health Services	1	2010	645	0.230	Why?
Drug Discovery	2	2010	1051	0.230	Why?
Neurosciences	1	2008	366	0.230	Why?
Delivery of Health Care	7	2010	5335	0.220	Why?
Chronic Disease	7	2022	9320	0.220	Why?
Digoxin	1	2004	246	0.210	Why?
Mortality	4	2007	2900	0.210	Why?
Commerce	1	2008	606	0.210	Why?
Medicare	8	2009	6770	0.210	Why?
Humans	95	2022	761423	0.210	Why?
Clergy	1	2003	79	0.200	Why?
Managed Care Programs	1	2007	940	0.200	Why?
Narcotics	1	2004	336	0.200	Why?
Parasympatholytics	1	2002	89	0.200	Why?
Dopamine Antagonists	1	2002	288	0.200	Why?
Urban Population	1	2010	2036	0.190	Why?
Adolescent	30	2010	88313	0.190	Why?
Specialization	1	2006	779	0.190	Why?
Bipolar Disorder	3	2007	5091	0.190	Why?
Muscarinic Antagonists	1	2002	135	0.190	Why?
Lipoproteins, HDL	1	2005	675	0.190	Why?
Evidence-Based Medicine	3	2010	3687	0.180	Why?
Occupational Health	1	2007	806	0.180	Why?
Insurance Claim Review	2	2004	741	0.180	Why?
Cholinergic Antagonists	1	2002	168	0.180	Why?
Male	59	2010	360736	0.180	Why?
Osteoarthritis	2	2006	1060	0.180	Why?
Psychiatric Status Rating Scales	8	2007	6019	0.180	Why?
Employment	2	2008	1118	0.180	Why?
Female	61	2010	392581	0.180	Why?
New Jersey	7	2006	295	0.180	Why?
Fluvoxamine	2	2010	78	0.180	Why?
Patient Dropouts	3	2009	412	0.180	Why?
Gastrointestinal Diseases	2	2006	1199	0.170	Why?
Logistic Models	10	2007	13255	0.170	Why?
Death, Sudden	1	2002	302	0.170	Why?
Anti-Arrhythmia Agents	1	2004	773	0.170	Why?
Health Services Accessibility	6	2010	5441	0.170	Why?
Central Nervous System Diseases	1	2004	520	0.170	Why?
Patient Care Team	2	2010	2523	0.170	Why?
Population Surveillance	2	2007	2597	0.160	Why?
Paroxetine	2	2010	182	0.160	Why?
Aged	38	2022	169235	0.160	Why?
Markov Chains	4	2006	966	0.160	Why?
Adult	38	2010	221148	0.160	Why?
Louisiana	2	2007	103	0.150	Why?
Medicine	1	2006	941	0.150	Why?
Clinical Trials as Topic	3	2010	8000	0.150	Why?
Cross-Sectional Studies	12	2010	26112	0.150	Why?
Quality of Health Care	3	2010	4330	0.150	Why?
Medicaid	4	2007	2818	0.150	Why?
Middle Aged	35	2010	220826	0.150	Why?
Hypertension	5	2005	8542	0.140	Why?
Urinary Incontinence	1	2002	489	0.140	Why?
Hypnotics and Sedatives	1	2005	1179	0.140	Why?
Citalopram	2	2010	402	0.140	Why?
Randomized Controlled Trials as Topic	3	2009	10203	0.140	Why?
Survivors	1	2007	2371	0.140	Why?
Cohort Studies	13	2010	41446	0.140	Why?
Quality-Adjusted Life Years	4	2009	1722	0.140	Why?
Age of Onset	4	2008	3304	0.140	Why?
Cholesterol	1	2005	2902	0.140	Why?
Biomedical Research	2	2010	3429	0.130	Why?
Fluoxetine	2	2010	733	0.130	Why?
Research Support as Topic	2	2010	697	0.130	Why?
Risk Assessment	8	2009	23990	0.130	Why?
Osteoporosis	1	2005	1605	0.130	Why?
Health Care Costs	1	2009	3243	0.130	Why?
Bone Density	2	2005	3551	0.130	Why?
Severity of Illness Index	7	2009	15838	0.130	Why?
Adrenal Cortex Hormones	1	2004	1876	0.120	Why?
Health Status	2	2006	4075	0.120	Why?
Decision Support Systems, Clinical	1	2004	1175	0.120	Why?
Models, Theoretical	1	2006	3576	0.120	Why?
Aged, 80 and over	18	2010	58956	0.120	Why?
Risk	5	2010	9612	0.120	Why?
Diagnostic and Statistical Manual of Mental Disorders	6	2007	1988	0.120	Why?
Cause of Death	4	2010	3684	0.120	Why?
Occupations	2	2006	515	0.110	Why?
Patient Acceptance of Health Care	3	2007	3204	0.110	Why?
Income	4	2008	1876	0.110	Why?
Anxiety	3	2022	4572	0.110	Why?
Complementary Therapies	3	2009	486	0.110	Why?
Family Practice	2	2006	512	0.110	Why?
Proportional Hazards Models	5	2010	12456	0.110	Why?
Mexico	3	2010	763	0.100	Why?
Benzodiazepines	3	2007	1132	0.100	Why?
Sampling Studies	2	2004	615	0.100	Why?
Probability	6	2009	2478	0.100	Why?
Age Distribution	2	2008	2880	0.100	Why?
Anxiety Disorders	5	2009	2717	0.100	Why?
Costs and Cost Analysis	2	2007	1668	0.090	Why?
Pennsylvania	6	2007	613	0.090	Why?
Treatment Outcome	8	2010	64651	0.090	Why?
Drug Utilization	5	2009	1188	0.090	Why?
Diagnosis, Dual (Psychiatry)	3	2007	303	0.090	Why?
Risk Factors	13	2010	74167	0.080	Why?
Needs Assessment	2	2007	1139	0.080	Why?
Drug Utilization Review	2	2007	248	0.080	Why?
Health Planning Guidelines	1	2010	151	0.080	Why?
Insurance, Pharmaceutical Services	2	2009	348	0.080	Why?
Interviews as Topic	2	2008	2696	0.080	Why?
Sertraline	1	2010	209	0.080	Why?
Prescription Fees	1	2010	153	0.080	Why?
Pharmacoepidemiology	3	2007	350	0.080	Why?
Public Health	1	2002	2666	0.080	Why?
Self Care	2	2004	796	0.080	Why?
Diabetes Mellitus	3	2005	5840	0.080	Why?
Utilization Review	1	2010	382	0.080	Why?
Odds Ratio	4	2008	9645	0.080	Why?
Imipramine	1	2008	98	0.080	Why?
Anti-Inflammatory Agents, Non-Steroidal	3	2006	2273	0.080	Why?
Dementia	3	2007	2686	0.070	Why?
Therapies, Investigational	1	2008	111	0.070	Why?
Cyclooxygenase 2 Inhibitors	2	2006	321	0.070	Why?
Dibenzothiazepines	1	2007	102	0.070	Why?
Ambulatory Care	2	2009	2775	0.070	Why?
Southeastern United States	1	2007	91	0.070	Why?
Adrenergic Uptake Inhibitors	1	2008	186	0.070	Why?
Activities of Daily Living	2	2007	2421	0.070	Why?
Chi-Square Distribution	2	2003	3418	0.070	Why?
National Health Programs	1	2010	440	0.070	Why?
Prepaid Health Plans	1	2006	9	0.070	Why?
Mass Screening	3	2007	5428	0.070	Why?
Pharmaceutical Services	1	2007	141	0.070	Why?
Multivariate Analysis	5	2007	12058	0.060	Why?
Health Services Misuse	1	2007	244	0.060	Why?
Allied Health Personnel	1	2007	155	0.060	Why?
Risperidone	1	2007	381	0.060	Why?
Stroke	1	2007	9756	0.060	Why?
Drug Evaluation	1	2006	642	0.060	Why?
Hospitals, Psychiatric	1	2006	321	0.060	Why?
Death Certificates	1	2006	167	0.060	Why?
Health Services for the Aged	1	2007	259	0.060	Why?
Comparative Effectiveness Research	1	2010	709	0.060	Why?
Retrospective Studies	9	2022	80582	0.060	Why?
Child	8	2010	80162	0.060	Why?
Databases, Factual	3	2010	7956	0.060	Why?
Administration, Oral	3	2008	4016	0.060	Why?
Pravastatin	2	2006	392	0.060	Why?
Salaries and Fringe Benefits	1	2006	257	0.060	Why?
Quinolones	1	2007	378	0.060	Why?
Self-Injurious Behavior	1	2010	566	0.060	Why?
Telephone	1	2007	627	0.060	Why?
Remission Induction	1	2009	2395	0.060	Why?
Patient Education as Topic	2	2004	2319	0.060	Why?
Patient Care Management	1	2006	302	0.050	Why?
Psychiatry	2	2006	1692	0.050	Why?
Treatment Failure	1	2009	2642	0.050	Why?
Public Health Informatics	1	2004	109	0.050	Why?
Direct Service Costs	1	2002	59	0.050	Why?
Product Surveillance, Postmarketing	1	2007	452	0.050	Why?
Angiotensin II Type 1 Receptor Blockers	1	2005	431	0.050	Why?
Risk Adjustment	2	2004	600	0.050	Why?
Secondary Prevention	1	2009	1474	0.050	Why?
Early Diagnosis	1	2008	1186	0.050	Why?
Role	1	2003	176	0.050	Why?
Lipoproteins, LDL	1	2005	642	0.050	Why?
Life Change Events	1	2007	952	0.050	Why?
Research Design	2	2009	6178	0.050	Why?
Age Factors	5	2009	18400	0.050	Why?
Longitudinal Studies	2	2009	14599	0.050	Why?
Monitoring, Physiologic	1	2009	1780	0.050	Why?
Disaster Planning	1	2007	557	0.050	Why?
Hypolipidemic Agents	1	2006	609	0.050	Why?
Reimbursement Mechanisms	1	2007	667	0.050	Why?
Hospitals, Veterans	1	2004	395	0.050	Why?
Arthritis	2	2004	682	0.050	Why?
Hyperlipidemias	1	2006	771	0.050	Why?
Time Factors	4	2009	39975	0.050	Why?
Calibration	1	2003	818	0.050	Why?
Geriatric Assessment	1	2009	1409	0.050	Why?
Health Maintenance Organizations	1	2004	660	0.050	Why?
Psychotherapy	2	2007	1647	0.050	Why?
Prolactin	1	2002	625	0.040	Why?
Confidence Intervals	2	2006	2927	0.040	Why?
Hospital Costs	1	2006	948	0.040	Why?
Social Class	1	2009	2004	0.040	Why?
Quality Assurance, Health Care	2	2010	2169	0.040	Why?
Hospitalization	2	2010	10718	0.040	Why?
Marital Status	1	2002	426	0.040	Why?
Thiazoles	1	2007	1517	0.040	Why?
Treatment Refusal	1	2003	429	0.040	Why?
Medical Records Systems, Computerized	1	2006	1192	0.040	Why?
Anticholesteremic Agents	2	2006	967	0.040	Why?
Data Collection	1	2009	3322	0.040	Why?
Efficiency, Organizational	1	2003	695	0.040	Why?
Medical Records	1	2004	1407	0.040	Why?
Government Programs	1	2021	279	0.040	Why?
Angiotensin-Converting Enzyme Inhibitors	1	2005	1517	0.040	Why?
Referral and Consultation	2	2010	3600	0.040	Why?
Education	1	2002	536	0.040	Why?
Life Expectancy	1	2005	1242	0.040	Why?
Breast Neoplasms	2	2003	21012	0.040	Why?
Alcoholism	1	2009	1973	0.040	Why?
Tamoxifen	1	2003	965	0.040	Why?
Internal Medicine	1	2005	1051	0.040	Why?
Medication Adherence	1	2009	2176	0.040	Why?
Cross-Over Studies	1	2004	2076	0.040	Why?
Occupational Exposure	1	2008	1813	0.040	Why?
Canada	3	2010	2120	0.040	Why?
Insurance Coverage	1	2009	1940	0.040	Why?
Poverty	1	2009	2697	0.040	Why?
Models, Statistical	2	2009	5077	0.040	Why?
Sensitivity and Specificity	2	2010	14664	0.040	Why?
Low Back Pain	1	2006	984	0.040	Why?
Socioeconomic Factors	3	2008	7825	0.040	Why?
Case-Control Studies	3	2004	22168	0.040	Why?
Piperazines	1	2007	2523	0.040	Why?
Sulfonamides	1	2006	1975	0.030	Why?
Insurance, Psychiatric	2	2009	69	0.030	Why?
Pyrazoles	1	2006	2007	0.030	Why?
Quality of Life	2	2009	13361	0.030	Why?
Sex Factors	2	2008	10548	0.030	Why?
Decision Support Techniques	1	2005	1998	0.030	Why?
Guideline Adherence	1	2005	2220	0.030	Why?
Interpersonal Relations	1	2002	1436	0.030	Why?
Dose-Response Relationship, Drug	2	2008	10766	0.030	Why?
Antineoplastic Agents, Hormonal	1	2003	1520	0.030	Why?
Linear Models	1	2004	5869	0.030	Why?
Insurance, Health	1	2006	2497	0.030	Why?
Health Expenditures	1	2007	2366	0.030	Why?
Nursing Homes	1	2002	1082	0.030	Why?
Attention	1	2004	2395	0.030	Why?
Diagnosis-Related Groups	2	2007	449	0.030	Why?
Follow-Up Studies	2	2006	39117	0.030	Why?
Pulmonary Disease, Chronic Obstructive	2	2005	3204	0.030	Why?
Pyridines	1	2005	2875	0.030	Why?
Circadian Rhythm	1	2004	2574	0.030	Why?
Stress, Psychological	1	2008	4477	0.030	Why?
Interview, Psychological	2	2008	809	0.030	Why?
Social Support	1	2002	2172	0.030	Why?
Regression Analysis	3	2007	6343	0.020	Why?
International Classification of Diseases	2	2010	909	0.020	Why?
Reproducibility of Results	5	2008	20093	0.020	Why?
Ontario	2	2002	398	0.020	Why?
Epidemiologic Studies	2	2006	675	0.020	Why?
Alzheimer Disease	2	2009	8596	0.020	Why?
Arthritis, Rheumatoid	1	2006	3755	0.020	Why?
Gastrointestinal Tract	2	2006	832	0.020	Why?
Primary Health Care	1	2006	4686	0.020	Why?
Hydroxymethylglutaryl-CoA Reductase Inhibitors	1	2005	3244	0.020	Why?
Analgesics, Opioid	1	2006	3804	0.020	Why?
Asthma	2	2005	6211	0.020	Why?
Clinical Coding	1	2010	181	0.020	Why?
Parents	1	2002	3564	0.020	Why?
Cardiovascular Diseases	4	2008	15498	0.020	Why?
Mental Health	1	2022	3249	0.020	Why?
Diclofenac	1	2006	68	0.020	Why?
Naproxen	1	2006	100	0.020	Why?
Organizational Case Studies	1	2007	301	0.020	Why?
Attitude to Health	2	2007	2025	0.020	Why?
Young Adult	5	2010	59207	0.020	Why?
Myocardial Infarction	1	2006	11458	0.020	Why?
Antidepressive Agents, Tricyclic	1	2007	432	0.020	Why?
Ibuprofen	1	2006	229	0.020	Why?
Forecasting	2	2004	2928	0.010	Why?
Lactones	1	2006	317	0.010	Why?
State Government	1	2007	384	0.010	Why?
Sulfones	1	2006	447	0.010	Why?
Data Interpretation, Statistical	2	2004	2691	0.010	Why?
Scotland	1	2002	143	0.010	Why?
Insurance Claim Reporting	1	2003	166	0.010	Why?
Respiratory Tract Diseases	1	2008	748	0.010	Why?
Ireland	1	2002	171	0.010	Why?
Life Tables	1	2002	365	0.010	Why?
Software Design	1	2002	171	0.010	Why?
Combined Modality Therapy	2	2006	8529	0.010	Why?
Heart Murmurs	1	2002	93	0.010	Why?
Demography	1	2007	1648	0.010	Why?
Prostatic Neoplasms	1	2004	11118	0.010	Why?
Developed Countries	1	2004	449	0.010	Why?
Pandemics	1	2021	8641	0.010	Why?
Self-Assessment	1	2003	396	0.010	Why?
Patient-Centered Care	1	2010	1422	0.010	Why?
Drug Approval	1	2007	814	0.010	Why?
Rheumatic Diseases	1	2006	648	0.010	Why?
Antineoplastic Agents	1	2002	13637	0.010	Why?
Health Services	1	2004	752	0.010	Why?
Drug Therapy, Combination	1	2008	6309	0.010	Why?
Netherlands	1	2002	2221	0.010	Why?
Nervous System Diseases	1	2008	1666	0.010	Why?
Multicenter Studies as Topic	1	2002	1703	0.010	Why?
Neoplasms	2	2005	22164	0.010	Why?
Medically Uninsured	1	2002	836	0.010	Why?
Delirium	1	2008	1667	0.010	Why?
Animals	1	2008	168441	0.010	Why?
Disability Evaluation	1	2003	1836	0.010	Why?
Postmenopause	1	2005	2513	0.010	Why?
Myocardial Ischemia	1	2006	2110	0.010	Why?
Program Evaluation	1	2003	2494	0.010	Why?
Prostate-Specific Antigen	1	2004	2469	0.010	Why?
Mastectomy	1	2003	1822	0.010	Why?
Chemotherapy, Adjuvant	1	2003	3514	0.010	Why?
Predictive Value of Tests	1	2010	15262	0.010	Why?
Developing Countries	1	2004	2885	0.010	Why?
Algorithms	1	2010	14026	0.010	Why?
Practice Guidelines as Topic	1	2005	7389	0.000	Why?
Pain	1	2003	5071	0.000	Why?
Obesity	1	2005	12938	0.000	Why?
Infant	1	2002	36205	0.000	Why?
Child, Preschool	1	2002	42254	0.000	Why?

Wang's Networks

Click the

Explore

buttons for more information and interactive visualizations!

Concepts (353)

Explore

Co-Authors (31)

Explore

Similar People (60)

Explore

Same Department

Explore